Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6911566 | 0.77 | KDM4E (0.35) | KDM4EALDH1A1TDP1POLBPKM | |
| SCHEMBL1525278 | 0.75 | KDM4E (0.41) | KDM4EALDH1A1TDP1POLBPKM | |
| SCHEMBL6910876 | 0.73 | KDM4E (0.35) | KDM4EALDH1A1TDP1POLBPKM | |
| SCHEMBL6905685 | 0.72 | KDM4E (0.36) | KDM4EALDH1A1TDP1POLBCDK1 | |
| SCHEMBL18030165 | 0.72 | KDM4E (0.39) | KDM4EALDH1A1TDP1POLBPKM | |
| SCHEMBL12532460 | 0.72 | KDM4E (0.39) | KDM4EALDH1A1TDP1POLBPKM | |
| SCHEMBL14724419 | 0.71 | — | — | |
| SCHEMBL16662005 | 0.71 | — | — | |
| SCHEMBL9185685 | 0.70 | KDM4E (0.45) | KDM4EALDH1A1TDP1POLBPKM | |
| SCHEMBL13354403 | 0.68 | KDM4E (0.37) | KDM4EALDH1A1TDP1POLBPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1320540-B9 | PEPTIDOMIMETIC PROTEASE INHIBITORS | VERTEX PHARMA (US) | 2012-03-21 | — | — | EP | disclosed |